Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial

NCT03655886 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT03655886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03655886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
August 15, 2018
Completion date
December 31, 2024
Enrollment
43 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer metastatic